Latest Articles

Publication Date
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Subverting tropes, merging goth with food: Arunima Tenzin's debut novel - MSN

Subverting tropes, merging goth with food: Arunima Tenzin's debut novel MSN

Published: April 18, 2025, 1:55 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery - Cureus

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery Cureus

Published: April 17, 2025, 11:08 p.m.
Why Saying Endometriosis Is Simply a “Bad Period” Is So, So Wrong - Cosmopolitan

Why Saying Endometriosis Is Simply a “Bad Period” Is So, So Wrong Cosmopolitan

Published: April 17, 2025, 9:28 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
IBS and endometriosis patients could face delays due to NHS waiting list changes - The i Paper

IBS and endometriosis patients could face delays due to NHS waiting list changes The i Paper

Published: April 17, 2025, 4:15 p.m.
Tiffany Haddish: 'If Men Had Period Pain, Weed Would Already Be Legal' - Benzinga

Tiffany Haddish: 'If Men Had Period Pain, Weed Would Already Be Legal' Benzinga

Published: April 17, 2025, 3:27 p.m.
Pearsanta to begin study of endometriosis test with IRB approval - Medical Device Network

Pearsanta to begin study of endometriosis test with IRB approval Medical Device Network

Published: April 17, 2025, 10:54 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!